AD-SMART Alzheimer’s Platform Trial Launches in the UK
Dementia ResearcherAD-SMART, a new UK platform trial, will test several Alzheimer’s drugs at once, starting with two repurposed medicines used for diabetes and ADHD.
Research News
Experts set out what AI brain scan tools need to reach memory clinics
Sixteen experts agreed eight statements on what AI neuroimaging tools need before memory clinics can use them, from diverse training data to clinician trust.
PhD Salary in Europe: What Doctoral Candidates Are Paid in 29 Countries
What is a PhD salary in Europe? Eurodoc compares 29 countries and finds being employed or on a stipend matters more than where you study.
STEM PhDs: Why Background Still Shapes the Path to PhD
A major new report finds students from low-socioeconomic backgrounds are far less likely to reach a STEM PhD, even with a first from a top university.
The Economic Case for Prioritising Alzheimer’s Disease Policy in Europe
A Biogen-funded CRA analysis estimates that prioritising Alzheimer’s policy could save Europe’s five biggest economies €182 billion by 2036.
Tau strains keep their shape as they spread, mouse study shows
Tau filaments from Alzheimer’s and CBD brains made mouse tau copy their exact atomic structure, the clearest evidence yet that tau strains spread like prions.
Talks from the ARUK Thames Valley Public Research Day
Five talks from the ARUK Thames Valley Public Research Day in Oxford, with Hilary Evans-Newton, Clare Mackay, Helen Sloan, Kirsty Rogers and an expert panel.
Ready for a Cure: ARUK’s case for a joined-up UK dementia research system
A reminder of Alzheimer’s Research UK’s July report on UK dementia research: falling trial numbers, a fragile workforce, and three priorities for government.
15-Minute Speech Test for Dementia: Memory Services Wanted
MemoryTell has Innovate UK funding to test a 15-minute speech and language assessment in memory clinics, and wants to hear from memory services keen to get involved.
Who pays when free academic journals change the rules?
Hundreds of once-free academic journals now charge a fee. What drives the shift, and what does it mean for researchers with limited funds to publish their work?
World Alzheimer Report 2026: Key Findings on Dementia Clinical Trials
The World Alzheimer Report 2026 from ADI focuses on dementia clinical trials. Key findings, the ten recommendations, and what they mean for researchers.
Personalised falls prevention programmes may make no difference, Cochrane review finds
A Cochrane review led by the University of Exeter finds tailored falls prevention programmes probably work no better than simple advice and education.